國家衛生研究院 NHRI:Item 3990099045/7949
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12190/12972 (94%)
造訪人次 : 1060548      線上人數 : 544
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/7949


    題名: Targeting Akt signaling for treatment of advanced prostate cancer cells with caffeic acid phenethyl ester
    作者: Chuu, CP;Lin, HP;Su, LC;Lin, CY;Huo, C;Kuo, YY;Chu, SC
    貢獻者: Institute of Cellular and Systems Medicine;National Institute of Cancer Research
    摘要: Prostate cancer is one of the most common non-cutaneous carcinomas of men in Western countries. More than 80% of patients die from prostate cancer bone metastases. Androgen ablation therapy is the primary treatment for metastatic prostate cancer. However, most prostate cancer patients receiving the androgen ablation therapy will ultimately develop recurrent, castration-resistant tumors within 1-3 years after treatment. The median overall survival time is 1-2 years after tumor relapse. Chemotherapy is usually applied for treatment of metastatic hormone-refractory prostate cancer. However, they showed little effect on prolonging survival. Undesired side effects of these chemotherapeutic agents include toxic deaths, strokes, thrombosis, neutropenia, edema, dyspnea, malaise, and fatigue. Combining chemotherapeutic drugs with natural compounds of anticancer activities may reduce the dosage of chemotherapeutic drugs needed. More than 80% of prostate tumors acquire mutation or deletion of tumor suppressor phosphatase and tensin homolog (PTEN), a negative regulator of PI3K/Akt signaling, indicating that inhibition of PI3K/Akt might be a potential therapy for advanced prostate tumors. Our observations indicated that caffeic acid phenethyl ester (CAPE) treatment suppressed proliferation of different prostate cancer cell lines as well as tumor growth of PC-3 xenograft. CAPE treatment disturbed cell cycle progression in human prostate cancer cells. CAPE decreased protein expression of cyclin D1, cyclin E, SKP2, c-Myc, Akt1, Akt2, Akt3, total Akt, mTOR, Bcl-2, Rb, as well as phosphorylation of Rb, ERK1/2, Akt, mTOR, GSK3α, GSK3β, PDK1. In contrast, CAPE increased protein expression of KLF6 and p21Cip1. Combination of CAPE with chemotherapeutic drugs produced synergistic suppression effects. Our studies indicated that CAPE treatment affects Akt signaling in prostate cancer cells and CAPE administration may thus serve as a potential adjuvant therapy for advanced prostate cancer.
    日期: 2012-12
    關聯: Prostate Cancer Cells: Detection, Growth and Treatment. 2012 Dec:57-72.
    Link to: https://www.novapublishers.com/catalog/product_info.php?products_id=39452
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84895322242
    顯示於類別:[褚志斌] 圖書
    [其他] 圖書

    文件中的檔案:

    沒有與此文件相關的檔案.



    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋